Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=54df14e9-40c6-4756-b730-80a60332266f Date 12/6/2016 Company Name AccuVein Mailing Address 3245 New York 112 Huntington, NY 11763 USA Company Description The global leader in vein visualization. Projects a map of veins directly on the skin to access or avoiding veins for IVs, blood draw & injectables. Website http://www.accuvein.com Transaction Type Debt Transaction Amount $2,455,008 … Continue reading “AccuVein Receives $2,455,008 New Funding”
Category: New York
With Nod To Biden, Senate To Say Yes To “Cures” Spending, Reform Bill
The U.S. Senate cleared the way for the 21st Century Cures Act, an omnibus healthcare spending and reform bill, by voting 85-13 to end debate this evening. It passed the House with 392 votes last week. After a final Senate vote as early as tomorrow, it will head to President Obama’s desk. The president used … Continue reading “With Nod To Biden, Senate To Say Yes To “Cures” Spending, Reform Bill”
Uber Buys New York’s Geometric Intelligence to Power New A.I. Lab
Uber is ratcheting up its efforts to advance artificial intelligence technologies as it pushes down the road toward self-driving vehicles. The ride-hailing app company has launched Uber AI Labs, a new division based in San Francisco focused on A.I. and machine learning research. The initial core team is made up of the 15 employees of … Continue reading “Uber Buys New York’s Geometric Intelligence to Power New A.I. Lab”
With Cowboys’ Backing, Blue Star Set to Boost Sports Startups
Dallas—Partners with a deep well of subject matter expertise and capital are on the top of any entrepreneur’s wish list. Now an accelerator tailored to sports technology startups might be giving those founders a connection to the ultimate in sports and marketing royalty: the Dallas Cowboys. The new Blue Star Accelerator, aimed at nurturing young … Continue reading “With Cowboys’ Backing, Blue Star Set to Boost Sports Startups”
The Xconomy Immuno-Oncology Resource: A Mid-ASH T Cell Update
[Updated, 12/5/16, 4 p.m. See below.] If you’re following cancer immunotherapy, you might feel a bit swamped by this week’s wave of clinical data from experimental programs that turn living T cells into revved-up cancer fighters. We’re updating our ongoing cancer immunotherapy trial resource with American Society of Hematology results, plus a few others we’ve … Continue reading “The Xconomy Immuno-Oncology Resource: A Mid-ASH T Cell Update”
Acetylon Crafts New Buyout Deal With Celgene, Spins Out Startup Regenacy
[Updated, 12/5/16, see below] Earlier this year, Celgene passed on an exclusive option to buy Acetylon Pharmaceuticals. But surprisingly, the two companies have come up with a new deal instead. Celgene agreed Friday to acquire just a portion of the assets of the Boston company, which will spin the rest of its assets into a … Continue reading “Acetylon Crafts New Buyout Deal With Celgene, Spins Out Startup Regenacy”
This Week in Drug Pricing and Post-Election Healthcare Policy News
Healthcare news has been coming fast and furious in the fallout of the election, particularly this week. Read on below for the latest on the 21st Century Cures Act, the Trump Administration’s latest nominees, and a biopharma CEO’s warning to his peers on drug pricing. IN WASHINGTON… —The House of Representatives passed a sweeping healthcare … Continue reading “This Week in Drug Pricing and Post-Election Healthcare Policy News”
Bio Roundup: CAR-T Ups & Downs, Lilly’s Failure, Myeloma & More
We’ve packed some extra stuffing into the roundup this week to account for some burnt turkey delivered by biopharma in the few days before Thanksgiving—starting with Eli Lilly’s failed gamble in Alzheimer’s disease. Lilly wasn’t alone, however. Several companies, among them Juno Therapeutics, Arrowhead Pharmaceutials, and Nivalis Therapeutics, have had some bad news for investors … Continue reading “Bio Roundup: CAR-T Ups & Downs, Lilly’s Failure, Myeloma & More”
An Innovation Snapshot of Medellin, Colombia
As we fly over Cuba en route from Fort Lauderdale to Medellin, I am already imbibing the upcoming culture change from the happy chaos at the departure gate in Florida. The plane is surprisingly not full and my fellow passengers, primarily Hispanics, are in a sleepy good mood. We will be arriving at 1am and … Continue reading “An Innovation Snapshot of Medellin, Colombia”
Glossier Receives $24,000,000 Series B Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a12f8088-8eda-4b26-bfdf-12d1e8ca1c1a Date 12/1/2016 Company Name Glossier Mailing Address 123 Lafayette St. New York, NY 10013 USA Company Description We are building a modern beauty brand inspired by real life. We’re creating new essentials informed by you, by our friends, by high-low culture (fashion, art, the Internet), and that celebrate what it means … Continue reading “Glossier Receives $24,000,000 Series B Funding”
Gett Obtains $100,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dddbc693-c5c1-4698-b8f2-1a4a38dabe2e Date 12/1/2016 Company Name Gett Mailing Address 237 West 35th St. New York, NY 10001 USA Company Description Gett is a large on-demand car service company by revenues and is the leading player in the B2B space globally. Website http://www.gettaxi.com Transaction Type Debt Transaction Amount $100,000,000 Transaction Round Undisclosed Proceeds Purposes … Continue reading “Gett Obtains $100,000,000 New Round”
Vector Media Receives New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=16ef4659-38ed-4c95-ab11-7b004f35d1ef Date 12/1/2016 Company Name Vector Media Mailing Address 560 Lexington Avenue New York, NY 10022 USA Company Description Vector Media offers diverse Out-of-Home advertising opportunities, specializing in large format visual communications. We focus on providing our clients with the tools to create maximum impact and brand experiences. Website http://www.vectormedia.com Transaction Type … Continue reading “Vector Media Receives New Financing”
Brushing Aside Critics, House Votes in Landslide for Cures Act
By a 392 to 26 vote, the U.S. House of Representatives has passed the omnibus healthcare legislation called the 21st Century Cures Act, bringing new funding for top Obama administration health priorities a big step closer to the outgoing president’s signature. While critics of the bill questioned whether that funding would actually materialize in coming … Continue reading “Brushing Aside Critics, House Votes in Landslide for Cures Act”
In Year of CAR-T Trouble, Can Bluebird, Penn Make Headway in Myeloma?
Several drugs have been approved to treat multiple myeloma, a cancer of the bone marrow, in recent years. But it remains a nasty, persistent disease. Most everyone relapses. Two rival groups, Bluebird Bio and researchers at the University of Pennsylvania, are presenting data in coming days to make a case that a cutting-edge therapy known … Continue reading “In Year of CAR-T Trouble, Can Bluebird, Penn Make Headway in Myeloma?”
Founder Collective Closes Third Fund: $75M to Back Early-Stage Startups
Founder Collective has reloaded its stock of dry powder to fuel young startups. The venture firm today announced it has raised $75 million for its third fund, roughly the same aggregate size as its second. The firm was founded by a group of entrepreneurs in 2009, and launched with a $40 million seed-stage fund. Founder … Continue reading “Founder Collective Closes Third Fund: $75M to Back Early-Stage Startups”
RAM shift phase 2
[Editor’s note: Seattle-based sci-fi author Greg Bear has contemplated a day when intelligent machines, which are already assisting or replacing humans in manufacturing and transportation, could do his job, too. Indeed, a World Economic Forum study (PDF) predicts that technologies such as artificial intelligence and robotics will replace some 5 million jobs by 2020, while … Continue reading “RAM shift phase 2”
With $19M, Axial Becomes Latest Startup to Target Gut-Brain Connection
We’re still a long way from understanding how the trillions of bacteria that live in and on our bodies, known collectively as the human microbiome, affect our health and well-being. Despite those unknowns, a steady drip of companies have launched in recent years to explore those links and make drugs for a range of diseases. … Continue reading “With $19M, Axial Becomes Latest Startup to Target Gut-Brain Connection”
Trump Tabs Fiscal, Social Conservatives To Run U.S. Health Agencies
Two big pieces of the Trump healthcare puzzle have fallen into place. The President-elect’s transition team has nominated Georgia Republican congressman Tom Price to be Health and Human Services secretary. It has also tabbed Indiana health consultant Seema Verma to run the Centers for Medicare and Medicaid Services. In a statement, Rep. Fred Upton (R-MI), … Continue reading “Trump Tabs Fiscal, Social Conservatives To Run U.S. Health Agencies”
The Tough Questions You Must Discuss Before You Take the Money
If all goes well, the day will come when just one small thing will stand between you and funding for your startup: your signature on a term sheet. Most founders quickly sign on the line and get back to the business of growing their business. Smart ones set aside the paperwork, grab their business partners, … Continue reading “The Tough Questions You Must Discuss Before You Take the Money”
Celgene Invests More in GNS Healthcare For Machine Learning Software
Celgene has made a second investment in GNS Healthcare and is tapping into the firm’s data analytics software to boost Celgene’s drug discovery and development efforts. Under an agreement announced Tuesday, Celgene (NASDAQ: [[ticker:CELG]]) has licensed the rights to use GNS Healthcare’s “Reverse Engineering and Forward Simulation” software. The technology crunches reams of health data—from … Continue reading “Celgene Invests More in GNS Healthcare For Machine Learning Software”
Dick’s Sporting Goods Acquires GameChanger for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cfde0474-9dfe-4567-962f-23478f5b979d Date 11/29/2016 Company Name GameChanger Mailing Address 86 Chambers Street New York, NY 10007 USA Company Description GameChanger provides free stat tracking and team management tools for baseball, softball and basketball teams. Website http://www.gc.com Transaction Type M&A Transaction Amount Undisclosed Transaction Round Proceeds Purposes M&A Terms Financial terms of the deal … Continue reading “Dick’s Sporting Goods Acquires GameChanger for Undisclosed Sum”
Amicus Shares Fall On Another Bump in Rough Road To U.S. Fabry Nod
After more than a decade of ups and downs, Amicus Therapeutics in May won its first drug approval, of Fabry disease pill migalastat (Galafold), in Europe. But the Cranbury, N.J. company won’t see the drug sold in the U.S. for at least a few more years. Amicus (NASDAQ: [[ticker:FOLD]]) said this afternoon that the FDA … Continue reading “Amicus Shares Fall On Another Bump in Rough Road To U.S. Fabry Nod”
Should We Rewrite the Human Genome?
Scientists are engineering a new living thing: a radically modified version of the lowly bacterium E. coli. In an article in Science from August, researchers at Harvard University described an ongoing project to build the genetic code of E. coli from scratch, but with major revisions to create a new strain unlike any in existence. The modified E. coli is … Continue reading “Should We Rewrite the Human Genome?”
Perch Interactive Lands $999,999 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=17d241bb-54ec-4248-83e8-90d8695c5fa3 Date 11/24/2016 Company Name Perch Interactive Mailing Address 265 Canal Street New York, NY 10013 USA Company Description PERCH is a natural extension of the shopping experience. As customers touch and pick up products, PERCH places experiential media right at the moment when they are most engaged with the product. PERCH … Continue reading “Perch Interactive Lands $999,999 New Round”
NS1 Garners Series B Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=35800492-84de-4db0-a7d3-d1560e337c01 Date 11/24/2016 Company Name NS1 Mailing Address 16 Beaver Street 3rd Floor New York, NY 10004 USA Company Description NS1 converges real-time user, network, and infrastructure data to optimize delivery of mission critical applications and websites. Website http://www.ns1.com Transaction Type Venture Equity Transaction Amount Undisclosed Transaction Round Series B Proceeds Purposes … Continue reading “NS1 Garners Series B Round”
The Convergence of Information Technology and the Life Sciences
We are at an incredible inflection point in the traditionally distinct fields of information technology and the life sciences. These broad disciplines are converging to advance fields of study like computational biology and systems biology, resulting in new forms of therapeutics and diagnostics that could have a monumentally positive impact on human health. At DFJ … Continue reading “The Convergence of Information Technology and the Life Sciences”
Sluggish Year for IPOs, But Signs Abound of Post-Election Surge
Uncertainty surrounding this year’s presidential election has kept U.S. IPO activity at a sluggish pace—so sluggish, in fact, that this year could end with the fewest IPOs and the lowest level of capital raised since 2009, according to PitchBook data for the first nine months of 2016. But this is no time to trash talk … Continue reading “Sluggish Year for IPOs, But Signs Abound of Post-Election Surge”
LiveRamp Acquires Arbor for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4433b153-82ef-4c53-b6a5-61eef3f6d9fd Date 11/22/2016 Company Name Arbor Mailing Address 1 State Street 35 Floor New York, NY 10004 USA Company Description Arbor (formerly known as Pippio) operates the first marketplace for people-based data. Publishers and app developers are empowered to surface, value, and fully monetize their data asset in a privacy-friendly, transparent manner. … Continue reading “LiveRamp Acquires Arbor for Undisclosed Sum”
Acorda Leans on Parkinson’s Drugs After Post-Stroke Study Fails
Acorda Therapeutics has tried for some time to expand the use of its flagship drug, dalfampridine (Ampyra). Demonstrating that it could help people walk better after suffering a stroke was perhaps its biggest opportunity. But the Ardsley, NY, company is now scrapping those plans altogether. Acorda (NASDAQ: [[ticker:ACOR]]) said this morning it will no longer … Continue reading “Acorda Leans on Parkinson’s Drugs After Post-Stroke Study Fails”
Electric Secures $2,000,000 Seed Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=588a9395-98b0-47fb-814e-0e7695c683e1 Date 11/21/2016 Company Name Electric Mailing Address Undisclosed New York, NY 11001 USA Company Description Electric allows small and mid sized corporate customers to get IT support across organizations directly through Slack, providing a real-time chat interface that provides users with the ability to get assistance with issues pertaining to their … Continue reading “Electric Secures $2,000,000 Seed Funding”
AdvisorEngine Obtains $20,000,000 Series A Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c64e7932-7027-40e2-9ae2-9255d3cec645 Date 11/21/2016 Company Name AdvisorEngine Mailing Address 60 Hudson Street 18th Floor New York, NY 10013 USA Company Description Finally, a digital platform that works the way you work – your investment philosophy, your workflows, your brand, your client relationships. Website http://www.advisorengine.com Transaction Type Venture Equity Transaction Amount $20,000,000 Transaction Round … Continue reading “AdvisorEngine Obtains $20,000,000 Series A Funding”
Syntimmune Lands $8,000,000 Series A Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=249d0be3-09de-46a9-ab52-9a8d8e474c54 Date 11/21/2016 Company Name Syntimmune Mailing Address 257 Park Avenue South 15th Floor New York, NY 10010 USA Company Description Founded in 2013, Syntimmune is the world’s leader in the biology of the neonatal Fc receptor (FcRn). Helmed by the most recognized experts in its field, Syntimmune is positioned to rapidly … Continue reading “Syntimmune Lands $8,000,000 Series A Round”
3 Questions as DraftKings, FanDuel Agree to Fantasy Sports Merger
At long last, it’s official: DraftKings and FanDuel are merging to create an online fantasy sports behemoth. DraftKings announced the tie-up on its website, after weeks of rumors and news reports based on anonymous sources. Financial terms weren’t disclosed, but the news release calls the deal a “strategic merger of equals.” Here’s what we know … Continue reading “3 Questions as DraftKings, FanDuel Agree to Fantasy Sports Merger”
Bio Roundup: Trump’s Rx Silence, PCSK9 News, Amgen’s Migraines & More
Speculation swirled this week around the incoming U.S. president’s intent to make good on his angry campaign rhetoric on drug prices, while the Associated Press reported that naming-and-shaming—that is, Congress hauling executives into hearings and penning angry letters—certainly hasn’t done the trick. For one new kind of cholesterol drug, insurers and their agents have tried … Continue reading “Bio Roundup: Trump’s Rx Silence, PCSK9 News, Amgen’s Migraines & More”
T-REX Group Lands $10,000,000 Series B Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=89e75311-c6b0-4f5b-a1b4-0ab034848af2 Date 11/18/2016 Company Name T-REX Group Mailing Address 214 W 29th Street 17th Floor New York, NY 10001 USA Company Description T-REX brings together world-class expertise in finance, renewables, and technology to support the development of sustainable, market-driven economics in the renewable energy industry. Website http://www.trexgroup.com Transaction Type Venture Equity Transaction … Continue reading “T-REX Group Lands $10,000,000 Series B Funding”
CoverWallet Receives $7,800,000 Series A Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f5ce2f2f-1478-4712-a0ed-646b47a4369e Date 11/18/2016 Company Name CoverWallet Mailing Address 85 Broad Street New York, NY 10004 USA Company Description The easiest way to understand, buy and manage insurance for your business, all online Website http://www.coverwallet.com Transaction Type Venture Equity Transaction Amount $7,800,000 Transaction Round Series A Proceeds Purposes Proceeds purposes were not disclosed. … Continue reading “CoverWallet Receives $7,800,000 Series A Funding”
Syntimmune Taps Ex-Boehringer, Pfizer Exec as New CEO
New York-based Syntimmune has named David de Graaf, a former Boehringer-Ingelheim and Pfizer executive, its president and CEO. The startup has also appointed Burt Adelman, the former research chief of Dyax and previously Biogen, to its board of directors. Adelman was named a senior adviser to Syntimmune as well.
Regeneron: It’s Still Wait Until 2017 For Big Heart Drug Study
With the American Heart Association’s annual meeting in New Orleans underway this week, there’s been plenty of talk about the prospects of so-called PCSK9 inhibitors, a new class of cholesterol lowering drugs that has struggled to gain traction in the market. Though evidence is being accumulated to prove their worth, the biggest piece of proof—data … Continue reading “Regeneron: It’s Still Wait Until 2017 For Big Heart Drug Study”
How to Lower Drug Prices, Improve Care, and Save Pharma
I recently received a note from a longtime friend who questioned me on the issue of pharma pricing. I answered with the always-reliable alleviating-the-scourge-of-disease-through-the-miracle-of-modern-medicine defense of “free-market pricing.” My friend, who is not in the pharmaceutical business, responded: The fundamental flaw in your argument centers on the notion that there is any relevance to “market … Continue reading “How to Lower Drug Prices, Improve Care, and Save Pharma”
Viyet Secures $4,012,825 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1da703bb-cbff-4abb-a0bf-44664b5380c5 Date 11/17/2016 Company Name Viyet Mailing Address 584 Broadway New York, NY 10012 USA Company Description Viyet is the design aficionado’s destination to buy and sell timeless furniture and accessories. We make it easy for owners of high-end furniture to sell their pieces when it comes time to move or redecorate. … Continue reading “Viyet Secures $4,012,825 New Round”
Led by Former Lilly Exec, Apexian Out to Tackle Pancreatic Cancer
Pancreatic cancer’s standard of care includes a drug that does not help most people diagnosed with the disease. Gemcitabine (Gemzar) works in only about 10 percent of patients, says Steve Carchedi, CEO of Apexian Pharmaceuticals. Carchedi knows about gemcitabine’s limitations because he worked at Eli Lilly (NYSE: [[ticker:LLY]]) when the FDA approved the Indianapolis-based company’s … Continue reading “Led by Former Lilly Exec, Apexian Out to Tackle Pancreatic Cancer”
East Meet East Garners $1,000,000 Seed Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0acf8dfa-f47f-4eb5-8aa7-58e83a9731a7 Date 11/16/2016 Company Name East Meet East Mailing Address 110 Wall Street 4rd Floor New York, NY 10005 USA Company Description EastMeetEast is exclusively dedicated to Asiandating. This means our members already have one important thing in common – they’re looking for someone with a similar cultural background. In other words, … Continue reading “East Meet East Garners $1,000,000 Seed Funding”
xAD Secures $42,500,000 Series E Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6fc83320-f89b-48ad-8cd6-8d5a32c01fcf Date 11/16/2016 Company Name xAD Mailing Address 401 Park Avenue South 11th Floor New York, NY 10016 USA Company Description xAD publishers and advertisers benefit from the scale and reach of the LocalAdXchange platform. The LocalAdXchange manages billions of search and ad requests with the largest combined network of local and … Continue reading “xAD Secures $42,500,000 Series E Funding Round”
Logz.io Obtains $16,000,000 Series B Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b0031cbd-6cfe-4ba2-8413-bda15f85a9f4 Date 11/16/2016 Company Name Logz.io Mailing Address 154 Grand Street New York, NY 10013 USA Company Description Logz.io launched today with $8M in financing led by 83North and Giza Venture Capital. The funding will fuel product development, sales, and marketing. Website http://www.logz.io Transaction Type Venture Equity Transaction Amount $16,000,000 Transaction Round … Continue reading “Logz.io Obtains $16,000,000 Series B Funding”
Scroll Garners $3,000,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=664fe2b6-fd50-4097-8a22-cb722ea7505a Date 11/16/2016 Company Name Scroll Mailing Address Undisclosed New York, NY 10023 USA Company Description There’s no shortage of great journalism online, but it is overwhelmed and underfunded in a distraction economy that neither values the work or its readers. No amount of contortions and compromises have made the business of … Continue reading “Scroll Garners $3,000,000 New Financing”
Siemplify Secures $10,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=90f9a6c6-8bc8-488c-b32f-dd1d03b09017 Date 11/16/2016 Company Name Siemplify Mailing Address 2 Rector St. New York, NY 10006 USA Company Description The Siemplify Threat Analysis Platform automatically correlates security alerts, identifies and prioritizes incidents, and graphically depicts the complete threat chain, setting new standards for time-to-insight and time-to-remediate. Website http://www.siemplify.co Transaction Type Venture Equity Transaction … Continue reading “Siemplify Secures $10,000,000 New Funding Round”
With New Data, Medicines Co. Takes Long-Lasting Heart Drug to Phase 3
The Medicines Co. and Alnylam Pharmaceuticals released new data today supporting a potentially longer lasting alternative to the widely hyped wave of cholesterol-fighting drugs that hit the market in 2015. But it’ll take more clinical testing, and likely several years, before the drug’s potential and commercial viability are proven. Today at the American Heart Association’s … Continue reading “With New Data, Medicines Co. Takes Long-Lasting Heart Drug to Phase 3”
The New Crowdfunding Rules: Will They Really Help Startups?
Hailed as the true democratizer of private investment, crowdfunding has been attracting both headlines and a fast-growing pile of cash. In May of 2016, rules from the Securities and Exchange Commission went into effect that will democratize the process even further. These new rules will open the doors to more investors, but they also pose … Continue reading “The New Crowdfunding Rules: Will They Really Help Startups?”
Boston Tech Hiring Cools, Despite More Expansion at Wayfair, Amazon
After more than a year of robust growth in payrolls at Boston-area software companies, local hiring cooled off in the third quarter. Boston digital-tech firms added just 250 net new jobs in the most recent quarter—a paltry 1.1 percent increase in the total number of digital-tech employees from the previous quarter. That’s according to the … Continue reading “Boston Tech Hiring Cools, Despite More Expansion at Wayfair, Amazon”
Siemplify Scores $10M to Streamline Cybersecurity Operations
Siemplify, a cyber-threat management and analysis firm with outposts in both Tel Aviv, Israel, and New York City, announced a $10 million round of Series A financing Tuesday, continuing what has been a busy month for cybersecurity investments across the country. The new investment, led by 83North Venture Capital and G20 Ventures, brings Siemplify’s total … Continue reading “Siemplify Scores $10M to Streamline Cybersecurity Operations”